Scientists Developed an Experimental Vaccine Against Rheumatoid Arthritis – “Totally Disappeared”

Rheumatoid Arthritis Hands

The University of Toledo researchers have created an experimental vaccine showing significant potential in preventing rheumatoid arthritis.

The protein-based vaccine shows significant promise in preventing rheumatoid arthritis and improving bone quality — suggesting long-term benefits following immunization.

Researchers at The University of Toledo have developed an experimental vaccine that shows significant promise in preventing rheumatoid arthritis, a painful autoimmune disease that cannot currently be cured.

“Much to our happy surprise, the rheumatoid arthritis totally disappeared in animals that received a vaccine.” — Dr. Ritu Chakravarti

The findings, detailed in a paper published in the journal Proceedings of the National Academy of Sciences, represent a major breakthrough in the study of rheumatoid arthritis and autoimmune diseases in general.

One of the most common autoimmune diseases, rheumatoid arthritis occurs when the body’s immune system attacks and breaks down healthy tissue — most notably the lining of joints in the hands, wrists, ankles, and knees.

Some estimates suggest rheumatoid arthritis affects as much as 1% of the global population.

“In spite of its high prevalence, there is no cure and we don’t entirely know what brings it on. This is true of nearly all autoimmune diseases, which makes treating or preventing them so difficult,” said Dr. Ritu Chakravarti, an assistant professor in the UToledo College of Medicine and Life Sciences and the paper’s lead author. “If we can successfully get this vaccine into the clinic, it would be revolutionary.”

Ritu Chakravarti

Dr. Ritu Chakravarti, assistant professor in The University of Toledo College of Medicine and Life Sciences, is the lead author of a new paper published in the Proceedings of the National Academy of Sciences detailing the creation of an experimental vaccine against rheumatoid arthritis. Credit: Daniel Miller, The University of Toledo

Chakravarti has for years studied a protein called 14-3-3 zeta and its role in immune pathologies, including aortic aneurysms and interleukin-17— a cytokine associated with autoimmune diseases. Based on their prior work, the research group was focused on the protein as a potential trigger for rheumatoid arthritis.

Instead, they found the opposite.

Rather than preventing rheumatoid arthritis, researchers discovered that removing the protein through gene-editing technology caused severe early onset arthritis in animal models.

Working under a new theory that the 14-3-3 zeta protein protects against rheumatoid arthritis, the team developed a protein-based vaccine using purified 14-3-3 zeta protein grown in a bacterial cell.

They found the vaccine promoted a strong and immediate — but long-lasting — response from the body’s innate immune system, providing protection against the disease.

“Much to our happy surprise, the rheumatoid arthritis totally disappeared in animals that received a vaccine,” Chakravarti said. “Sometimes there is no better way than serendipity. We happened to hit a wrong result, but it turned out to be the best result. Those kinds of scientific discoveries are very important in this field.”

In addition to suppressing the development of arthritis, the vaccine also significantly improved bone quality — a finding that suggests there should be long-term benefits following immunization.

Currently, rheumatoid arthritis is treated primarily with corticosteroids, broad scale immunosuppressive drugs or newer, more targeted biologics that target a specific inflammatory process.

While those therapeutics can alleviate pain and slow the progression of the disease, they also can make patients more vulnerable to infection and, in the case of biologics, can be costly.

“We have not made any really big discoveries toward treating or preventing rheumatoid arthritis in many years,” Chakravarti said. “Our approach is completely different. This is a vaccine-based strategy based on a novel target that we hope can treat or prevent rheumatoid arthritis. The potential here is huge.”

Researchers have filed for a patent on their discovery and are seeking pharmaceutical industry partners to support safety and toxicity studies in hopes of establishing a preclinical trial.

Reference: “14-3-3ζ: A suppressor of inflammatory arthritis” by Joshua Kim, Krista Chun, Jenna McGowan, Youjie Zhang, Piotr J. Czernik, Blair Mell, Bina Joe, Saurabh Chattopadhyay, Joseph Holoshitz and Ritu Chakravarti, 24 August 2021, Proceedings of the National Academy of Sciences.
DOI: 10.1073/pnas.2025257118

3 Comments on "Scientists Developed an Experimental Vaccine Against Rheumatoid Arthritis – “Totally Disappeared”"

  1. I’m guessing the drug will totally disappear too. Nothing makes it to market that “Cures” anything. What bullhit.

  2. Covid vaccine begs to differ? What do you mean nothing that cures illness makes it to market?

  3. Thanks for this information its is a readable and affective.

Leave a comment

Email address is optional. If provided, your email will not be published or shared.